human cervical cancer derived cell lines hela (ATCC)
Structured Review

Human Cervical Cancer Derived Cell Lines Hela, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 29054 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cervical cancer derived cell lines hela/product/ATCC
Average 99 stars, based on 29054 article reviews
Images
1) Product Images from "Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines"
Article Title: Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
Journal: BMC Cancer
doi: 10.1186/s12885-024-12555-5
Figure Legend Snippet: Metformin induces ZFP36 expression in cervical cancer-derived-cell lines. HeLa and CaSki cells were treated with metformin 20mM for 24 hours, then RNA was extracted for analysis by RT-qPCR. RT-qPCR of ZFP36 after metformin treatment in ( A ) HeLa and ( B ) CaSki. Representative Western Blot of ZFP36 and densitometric analysis in ( C ) HeLa and ( D ) CaSki, ( E ) HaCaT and ( F ) Human Uterine Fibroblast (HUF). Results are shown as means ± SD of at least three independent experiments. * p <0.05 **, p <0.01
Techniques Used: Expressing, Derivative Assay, Quantitative RT-PCR, Western Blot
Figure Legend Snippet: Metformin downregulates mTORC1/S6K1/rpS6 pathway and decreases cell viability in cervical cancer cell lines. HeLa and CaSki cells were treated with different metformin concentrations for 24 hours and, the levels of p-P70/P85 S6K1, p-rpS6, and p-AMPK were measured by Western Blot in HeLa cells ( A - C ) and CaSki cells ( D - F ). E and F HeLa cells and CaSki cells were treated with 5, 10, and 20 mM of metformin for 24 h. Then, cell viability was examined using an MTT assay. The plots represent the densitometric and statistical analysis of Western Blot and data expressed as mean + SD of at least three independent experiments. * p < 0.05, ** p < 0.01, **** p < 0.001
Techniques Used: Western Blot, MTT Assay
Figure Legend Snippet: ZFP36 is induced by mTORC1 inhibition in CC cells. HeLa and CaSki cells were treated with 50 nM rapamycin or with vehicle (ethanol) for 24 h, and the levels of ZFP36 and p-rpS6 were measured by Western Blot. A and B Corresponding Western Blot and densitometric analysis of ZFP36/GAPDH in HeLa cells. C and D Corresponding Western Blot and densitometric analysis of ZFP36/GAPDH in CaSki cells. E HeLa cells were transfected with control or AMPK-targeting siRNAs for 24 h, and the levels of AMPK and ZFP36 were measured by Western Blot. F Corresponding densitometric analysis of ZFP36/GAPDH. The plots represent the densitometric and statistical analysis of Western Blot and data expressed as mean + SD of at least three independent experiments. * p < 0.05, ** p < 0.01
Techniques Used: Inhibition, Western Blot, Transfection, Control
Figure Legend Snippet: Metformin inhibits mTORC1 and cell viability independently of AMPK. HeLa cells were transfected with control or AMPK-targeting siRNAs and treated or not with 20 mM metformin for 24 h. A Cell viability was examined using an MTT assay. B The levels of AMPK, p-rpS6, rpS6 were measured by Western Blot. C Corresponding densitometric analysis of p-rpS6/rpS6. Data expressed as mean + SD of at least three independent experiments. * p < 0.05, ** p < 0.01
Techniques Used: Transfection, Control, MTT Assay, Western Blot
